FDA: House Republicans Question Generic Drug Rulemaking Process
A large group of House Republicans is once against raising questions about the U.S. Food and Drug Administration's (FDA)…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
June 2014
Physician Payments Sunshine Act: PhRMA Urges CMS To Push Back June 30…
Last week, the Pharmaceutical Research and Manufacturers of America (PhRMA) wrote a letter to the Centers for Medicare…
Physician Payments Sunshine Act: Understand Physician Expectations and…
The 5th Aggregate Spend and Sunshine Conference, hosted by ExL Pharma, provided comprehensive insight into "lessons…
Accountable Care Update: Top ACO Providers
Accountable Care Organizations (ACOs) have proliferated throughout the United States in the past few years, but they are…
Accountable Care Organizations: Patients Look Elsewhere for Specialty Care
A study recently published in JAMA Internal Medicine found the majority of beneficiaries assigned to an accountable care…
FDA Social Media Guidance: Correcting Independent Third-Party…
The Food and Drug Administration (FDA) released two new guidances for drug and device companies looking to communicate…
FDA Social Media Guidance: Presenting Risks and Benefits With Social…
The Food and Drug Administration (FDA) released two new guidances for drug and device companies looking to communicate…
Physician Payments Sunshine Act: Issues To Watch For As You Submit Phase 2…
Pharmaceutical and device manufacturers must submit detailed data on payments to physicians and teaching hospitals to comply with…
New Enforcement Frontier? Medtronic Settles Medical Device Kickback Case…
A number of government attorneys have spoken at compliance conferences over the last year and noted that the days of…
GSK Settles for $105 Million Under State Consumer Protection Laws; Agrees…
GlaxoSmithKline reached a $105 million settlement with 44 states and D.C. to resolve allegations that the company unlawfully…